WASHINGTON (AP) — FDA APPROVAL: The Food and Drug Administration on Tuesday approved a new drug from Pfizer for treating a rare form of blood and bone-marrow cancer.
BAD BLOOD CELLS: Pfizer’s Bosulif is a daily pill to treat chronic myeloid leukemia, a disease that causes the bone marrow to produce unhealthy white blood cells. White blood cells are needed to help the body fight off infection.
ORPHAN DRUG: An estimated 5,430 patients will be diagnosed with chronic myelogenous leukemia this year, according to the FDA. The agency cleared Bosulif under its program for drugs intended to treat rare diseases.
Click here to comment on this story »